Original Article
Neuropsychopharmacology (2006) 31, 2739–2747. doi:10.1038/sj.npp.1301196; published online 23 August 2006
Clinical Research
Variations in the Vesicular Monoamine Transporter 1 Gene (VMAT1/SLC18A1) are Associated with Bipolar I Disorder
Falk W Lohoff1, John P Dahl1, Thomas N Ferraro1, Steven E Arnold1, Jürgen Gallinat2, Thomas Sander3 and Wade H Berrettini1
- 1Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
- 2Clinic for Psychiatry and Psychotherapy, Charité University Medicine Berlin, Berlin, Germany
- 3Max-Delbrück-Center, Gene Mapping Center, Berlin, Germany
Correspondence: Dr FW Lohoff, Department of Psychiatry, Translational Research Laboratory, Center for Neurobiology and Behavior, University of Pennsylvania School of Medicine, 125 South 31st Street, Philadelphia, PA 19104, USA. Tel: +1 215 573 4582, Fax: +1 215 573 2041, E-mail: lohoff@mail.med.upenn.edu
Received 21 February 2006; Revised 11 July 2006; Accepted 17 July 2006; Published online 23 August 2006.
Abstract
The vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) maps to the shared bipolar disorder (BPD)/schizophrenia (SZ) susceptibility locus on chromosome 8p21. Vesicular monoamine transporters are involved in transport of monoamine neurotransmitters which have been postulated to play a relevant role in the etiology of BPD and/or SZ. Variations in the VMAT1 gene might affect transporter function and/or expression and might be involved in the etiology of BPD and/or SZ. Genotypes of 585 patients with BPD type I and 563 control subjects were obtained for three missense single nucleotide polymorphisms (SNPs) (Thr4Pro, Thr98Ser, Thr136Ile) and four non-coding SNPs (rs988713, rs2279709, rs3735835, rs1497020). All cases and controls were of European descent. Allele frequencies differed significantly for the potential functional polymorphism Thr136Ser between BPD patients and controls (p=0.003; df=1; OR=1.34; 95% CI: 1.11–1.62). Polymorphisms in the promoter region (rs988713: p=0.005, df=1; OR=1.31; 95% CI: 1.09–1.59) and intron 8 (rs2279709: p=0.039, df=1; OR=0.84; 95% CI: 0.71–0.99) were also associated with disease. Expression analysis confirmed that VMAT1 is expressed in human brain at the mRNA and protein level. Results suggest that variations in the VMAT1 gene may confer susceptibility to BPD in patients of European descent. Additional studies are necessary to confirm this effect and to elucidate the role of VMAT1 in central nervous system physiology.
Keywords:
bipolar disorder, schizophrenia, linkage, association, VMAT1, SLC18A1
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Schizophrenia genetics: uncovering positional candidate genes
European Journal of Human Genetics Review
RESEARCH
Molecular Psychiatry Original Article
Excitement and confusion on chromosome 6q: the challenges of neuropsychiatric genetics in microcosm
Molecular Psychiatry Original Article
European Journal of Human Genetics Article Response
Extreme population differences across Neuregulin 1 gene, with implications for association studies
Molecular Psychiatry Original Article

